NCT06932770

Brief Summary

The aim of this study is to investigate the impact of a topical and an oral product alone and in combination compared to placebo on skin aging

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 10, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 17, 2025

Completed
6 days until next milestone

Study Start

First participant enrolled

April 23, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 17, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 17, 2025

Completed
Last Updated

July 25, 2025

Status Verified

July 1, 2025

Enrollment Period

3 months

First QC Date

April 10, 2025

Last Update Submit

July 24, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Anti-wrinkle efficacy

    Change from baseline in anti-wrinkles efficacy (assessed on three-dimensional structure of the wrinkles in the periorbital regions) after 6 and 12 weeks. Anti-wrinkle efficacy will be assessed using DermaTOP. Parameters measured: Rz and Ra, representing mainly the rough structure (Rz) or the finer skin structure (Ra).

    12 weeks

Secondary Outcomes (7)

  • Skin barrier function

    12 weeks

  • Skin hydration

    12 weeks

  • Skin firmness

    12 weeks

  • Skin elasticity

    12 weeks

  • Wrinkles and fine lines

    12 weeks

  • +2 more secondary outcomes

Study Arms (4)

Food supplement and cosmetic routine

EXPERIMENTAL

The "food supplement and cosmetic routine" arm will consume the food supplement active and apply the skin care product active.

Dietary Supplement: Food Supplement activeOther: Skin care product active

Food supplement

EXPERIMENTAL

The "food supplement" arm will consume the food supplement active and apply the skin care product placebo.

Dietary Supplement: Food Supplement activeOther: Skin care product placebo

Cosmetic routine

EXPERIMENTAL

The "cosmetic routine" arm will consume the food supplement placebo and apply the skin care product active.

Dietary Supplement: Food supplement placeboOther: Skin care product active

Placebo

PLACEBO COMPARATOR

The "placebo" arm will consume the food supplement placebo and apply the skin care product placebo.

Dietary Supplement: Food supplement placeboOther: Skin care product placebo

Interventions

Food Supplement activeDIETARY_SUPPLEMENT

The food supplement active (2 soft gels) will be consumed once per day with a large glass of water.

Food supplementFood supplement and cosmetic routine
Food supplement placeboDIETARY_SUPPLEMENT

The food supplement placebo (2 soft gels) will be consumed once per day with a large glass of water.

Cosmetic routinePlacebo

The cosmetic skin care product active will be applied twice daily to half of the face and to one volar forearm.

Cosmetic routineFood supplement and cosmetic routine

The cosmetic skin care product placebo will be applied twice daily to half of the face and to one volar forearm.

Food supplementPlacebo

Eligibility Criteria

Age40 Years - 70 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Written Informed Consent to participate in the study
  • Willingness to actively participate in the study and to come to the scheduled visits
  • Female
  • From 40 to 70 years of age, in order to include sufficient subjects for the study, if necessary, the age may be gradually increased to 70 years or decreased to 40 years
  • Healthy skin in the test areas
  • Visible wrinkles in the face (grade 3 to 6 according to proderm wrinkle score)
  • For biopsy subpanel:
  • \- Vaccination of tetanus within the last 10 years

You may not qualify if:

  • Female subjects: Pregnancy or lactation
  • Drug addicts, alcoholics
  • AIDS, HIV-positive or infectious hepatitis
  • Conditions which exclude a participation or might influence the test reaction/evaluation
  • Participation or being in the waiting period after participation in cosmetic and/or pharmaceutical studies pertaining to the test area
  • Active skin disease at the test area
  • Documented allergies to face/eye care products and food supplements or their ingredients
  • Intake of dietary supplements within the last 3 months before the start of the study
  • Diabetes mellitus
  • Cancer not being diagnosed as cured and requiring chemotherapy, irradiation and/or hormonal treatment within the last 2 years
  • Epilepsy
  • Wounds, moles, tattoos, scars, irritated skin, excessive hair growth, freckles, etc. at the test area that could influence the investigation
  • Regular use of tanning beds
  • Any topical medication at the test area within the last 3 days prior to the start of the study
  • Systemic therapy with immuno-suppressive drugs (e.g. corticosteroids) and/or antihistamines (e.g. antiallergics) and/or within the last 7 days prior to the start of the study
  • +9 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

SGS proderm GmbH

Schenefeld, Hamburg, 22869, Germany

Location

Study Officials

  • Katrin Unbereit

    SGS proderm GmbH

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Split-face design. Subjects will be divided equally in 2 treatment groups (food supplement active or food supplement placebo). Group 1 will receive treatments A and B (food supplement active with cosmetic active on one volar forearm and one side of face and cosmetic placebo on the other volar forearm and side of face) and group 2 C and D (food supplement placebo with cosmetic active on one volar forearm and one side of face and cosmetic placebo on the other volar forearm and side of face). Treatments will be randomly and balanced assigned to left and right test area in each group.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 10, 2025

First Posted

April 17, 2025

Study Start

April 23, 2025

Primary Completion

July 17, 2025

Study Completion

July 17, 2025

Last Updated

July 25, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations